Jorge Gomez Tejeda Zanudo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Androstadienes | 1 | 2024 | 348 | 0.800 |
Why?
|
| Estrogen Receptor alpha | 2 | 2021 | 581 | 0.700 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2021 | 905 | 0.580 |
Why?
|
| Piperazines | 2 | 2024 | 2554 | 0.520 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 757 | 0.490 |
Why?
|
| Thiazoles | 2 | 2021 | 1542 | 0.470 |
Why?
|
| Embryonic Development | 1 | 2019 | 724 | 0.450 |
Why?
|
| Pyridines | 2 | 2024 | 2894 | 0.410 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 21206 | 0.370 |
Why?
|
| Hyphae | 1 | 2021 | 52 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5341 | 0.320 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4912 | 0.300 |
Why?
|
| Plant Stomata | 1 | 2017 | 4 | 0.300 |
Why?
|
| Candida albicans | 1 | 2021 | 375 | 0.290 |
Why?
|
| Abscisic Acid | 1 | 2017 | 42 | 0.290 |
Why?
|
| Wound Healing | 1 | 2019 | 2809 | 0.290 |
Why?
|
| Plant Growth Regulators | 1 | 2017 | 51 | 0.290 |
Why?
|
| Models, Biological | 3 | 2021 | 9495 | 0.290 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11878 | 0.240 |
Why?
|
| Gene Regulatory Networks | 3 | 2019 | 1752 | 0.230 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.180 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 493 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 317 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 565 | 0.170 |
Why?
|
| Plants | 1 | 2021 | 332 | 0.170 |
Why?
|
| Algorithms | 4 | 2022 | 14164 | 0.170 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 771 | 0.170 |
Why?
|
| Receptor, erbB-2 | 2 | 2024 | 2603 | 0.160 |
Why?
|
| Models, Theoretical | 2 | 2021 | 3573 | 0.150 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 215 | 0.140 |
Why?
|
| Thiophenes | 1 | 2021 | 570 | 0.140 |
Why?
|
| Leukemia | 1 | 2015 | 1519 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1996 | 0.130 |
Why?
|
| Genomics | 3 | 2024 | 5926 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2021 | 23645 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2020 | 631 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2024 | 2059 | 0.110 |
Why?
|
| Feedback | 2 | 2022 | 799 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 2253 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4283 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 2333 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1901 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1982 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 17140 | 0.090 |
Why?
|
| Patient Participation | 1 | 2020 | 1447 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2021 | 3048 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 4362 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13676 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 9538 | 0.070 |
Why?
|
| Software | 1 | 2022 | 4478 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2021 | 6283 | 0.070 |
Why?
|
| Systems Biology | 1 | 2021 | 482 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2021 | 746 | 0.070 |
Why?
|
| Arabidopsis Proteins | 1 | 2017 | 261 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10474 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9523 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 482 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2017 | 466 | 0.060 |
Why?
|
| Leukemia, Large Granular Lymphocytic | 1 | 2013 | 24 | 0.050 |
Why?
|
| Female | 6 | 2024 | 397192 | 0.040 |
Why?
|
| Cadherins | 1 | 2014 | 905 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2021 | 412 | 0.040 |
Why?
|
| Gene Library | 1 | 2022 | 1064 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1750 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 768166 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 547 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2021 | 1760 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2021 | 1715 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2023 | 1733 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 5792 | 0.030 |
Why?
|
| Breast | 1 | 2023 | 1976 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1300 | 0.030 |
Why?
|
| Mutation | 2 | 2023 | 30238 | 0.030 |
Why?
|
| Cell Survival | 1 | 2013 | 5777 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 16726 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 3568 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2457 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4120 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2954 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 54926 | 0.020 |
Why?
|
| Genome, Human | 1 | 2020 | 4446 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8647 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9419 | 0.010 |
Why?
|
| Adult | 2 | 2023 | 223646 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 40218 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 82029 | 0.010 |
Why?
|
| Middle Aged | 2 | 2023 | 223492 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59629 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 60066 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 169246 | 0.010 |
Why?
|
| United States | 1 | 2020 | 73039 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 171504 | 0.000 |
Why?
|
| Male | 1 | 2023 | 364719 | 0.000 |
Why?
|